Penumbra Management
Management criteria checks 4/4
Penumbra's CEO is Adam Elsesser, appointed in Jun 2004, has a tenure of 20.42 years. total yearly compensation is $601.62K, comprised of 99.7% salary and 0.3% bonuses, including company stock and options. directly owns 2.27% of the company’s shares, worth $206.90M. The average tenure of the management team and the board of directors is 4.5 years and 8.7 years respectively.
Key information
Adam Elsesser
Chief executive officer
US$601.6k
Total compensation
| CEO salary percentage | 99.7% |
| CEO tenure | 20.4yrs |
| CEO ownership | 2.3% |
| Management average tenure | 4.5yrs |
| Board average tenure | 8.7yrs |
Recent management updates
Recent updates
Penumbra (NYSE:PEN) May Have Issues Allocating Its Capital
Oct 06
Penumbra Grinding Through A Painful Growth Expectations Reset
Aug 20What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/S
Aug 01Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate
Jul 11Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down
Jun 19Penumbra: Appeal Improves As Operating Leverage Continues
May 30Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors
Apr 12Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)
Mar 21Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital
Jan 23A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)
Nov 16Penumbra: Appeal Improves, Just Not Appealing Yet
Oct 16Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)
Oct 05Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy
Sep 01A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)
Aug 15Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger
Jun 28Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors
Jun 22Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult
Jun 02We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn
Apr 01Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M
Feb 23Penumbra Riding Higher On Upcoming Launches And Rerating
Jan 12Penumbra: Today's Best Medical Equipment Nearby Cap-Gain Buy
Nov 03Penumbra cut to Neutral at Citi on macro concerns
Oct 05Penumbra, Asahi team up to bring blood clot removing device Indigo to Japan
Sep 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$35m |
| Jun 30 2024 | n/a | n/a | US$14m |
| Mar 31 2024 | n/a | n/a | US$93m |
| Dec 31 2023 | US$602k | US$600k | US$91m |
| Sep 30 2023 | n/a | n/a | US$41m |
| Jun 30 2023 | n/a | n/a | US$29m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$602k | US$600k | -US$2m |
| Sep 30 2022 | n/a | n/a | -US$31m |
| Jun 30 2022 | n/a | n/a | -US$19m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | US$498k | US$496k | US$5m |
| Sep 30 2021 | n/a | n/a | US$34m |
| Jun 30 2021 | n/a | n/a | US$16m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | US$219k | US$217k | -US$16m |
| Sep 30 2020 | n/a | n/a | -US$10m |
| Jun 30 2020 | n/a | n/a | US$11m |
| Mar 31 2020 | n/a | n/a | US$39m |
| Dec 31 2019 | US$727k | US$725k | US$48m |
| Sep 30 2019 | n/a | n/a | US$45m |
| Jun 30 2019 | n/a | n/a | US$15m |
| Mar 31 2019 | n/a | n/a | US$12m |
| Dec 31 2018 | US$727k | US$725k | US$7m |
| Sep 30 2018 | n/a | n/a | US$9m |
| Jun 30 2018 | n/a | n/a | US$28m |
| Mar 31 2018 | n/a | n/a | US$13m |
| Dec 31 2017 | US$727k | US$725k | US$5m |
Compensation vs Market: Adam's total compensation ($USD601.62K) is below average for companies of similar size in the US market ($USD7.97M).
Compensation vs Earnings: Adam's compensation has been consistent with company performance over the past year.
CEO
Adam Elsesser (62 yo)
20.4yrs
Tenure
US$601,620
Compensation
Mr. Adam Elsesser serves as President at Penumbra, Inc. since May 2020. He Co-Founded Penumbra, Inc. in 2004 and has been its Chief Executive Officer and Director since June 2004. Mr. Elsesser has been the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 20.4yrs | US$601.62k | 2.27% $ 206.9m | |
| Co-Founder & Director | 20.4yrs | US$233.99k | 0.88% $ 80.0m | |
| Chief Financial Officer | 4.9yrs | US$666.04k | 0.017% $ 1.5m | |
| Chief Accounting Officer | 4.9yrs | US$539.94k | 0.041% $ 3.7m | |
| Executive VP | 6.2yrs | US$661.89k | 0.13% $ 12.1m | |
| Executive Vice President of Operations | 3.8yrs | no data | no data | |
| Executive VP & Chief Information Officer | 2.8yrs | no data | no data | |
| Investor Relations Officer | no data | no data | no data | |
| Executive Vice President of Development & Compliance | less than a year | no data | no data | |
| Executive VP & GM of Interventional | 1.8yrs | no data | no data | |
| Executive Vice President of Strategy | 4.5yrs | no data | no data | |
| Chief Medical Officer | 3.8yrs | no data | no data |
4.5yrs
Average Tenure
52yo
Average Age
Experienced Management: PEN's management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 20.4yrs | US$601.62k | 2.27% $ 206.9m | |
| Co-Founder & Director | 20.4yrs | US$233.99k | 0.88% $ 80.0m | |
| Independent Director | 9.6yrs | US$241.49k | 0.022% $ 2.0m | |
| Independent Director | 7.8yrs | US$258.99k | 0.012% $ 1.1m | |
| Presiding Independent Director | 16.8yrs | US$246.49k | 0.024% $ 2.2m | |
| Independent Director | 5.3yrs | US$248.99k | 0.0064% $ 583.3k | |
| Independent Director | 7.6yrs | US$263.99k | 0.011% $ 1.0m | |
| Independent Director | 5.8yrs | US$251.49k | 0.013% $ 1.1m |
8.7yrs
Average Tenure
60.5yo
Average Age
Experienced Board: PEN's board of directors are considered experienced (8.7 years average tenure).